UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014044
Receipt number R000016352
Scientific Title Efficay of urinary desmosine and isodesmosine in adlut asthma
Date of disclosure of the study information 2014/05/22
Last modified on 2015/03/19 13:54:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficay of urinary desmosine and isodesmosine in adlut asthma

Acronym

Urinary desmosines in asthma

Scientific Title

Efficay of urinary desmosine and isodesmosine in adlut asthma

Scientific Title:Acronym

Urinary desmosines in asthma

Region

Japan


Condition

Condition

Bronchial asthma

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficay of urinary desmosine and isodesmosine in adult asthma

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To confirm the correlation between urinary desmosines and the clinical parameters such as age, symptoms, pulmonary function test, expiratory NO concentration and respiratory resistance.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

stable adult bronchial asthma patients in our hospital

Key exclusion criteria

Patients with a smoking history of 10 pack-year or more

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takafumi Suda

Organization

Hamamatsu University School of Medicine

Division name

Second Division, Department of Internal Medicine

Zip code


Address

1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan

TEL

053-435-2263

Email

suda@hama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiyuki Oyama

Organization

Hamamatsu University School of Medicine

Division name

Second Division, Department of Internal Medicine

Zip code


Address

1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan

TEL

053-435-2263

Homepage URL


Email

y-oyama@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 05 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

In patients with asthma, urinary desmosine and isodesimosine did not seem to be useful biomarkers.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 06 Month 01 Day

Last follow-up date

2015 Year 03 Month 19 Day

Date of closure to data entry

2015 Year 03 Month 19 Day

Date trial data considered complete

2015 Year 03 Month 19 Day

Date analysis concluded

2015 Year 03 Month 19 Day


Other

Other related information

Urinary desimosine and isodesmosine did not correlate with parameters such as pulmonary function tests.


Management information

Registered date

2014 Year 05 Month 22 Day

Last modified on

2015 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016352


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name